Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Systemic sclerosis without antinuclear antibodies (ANA) or Raynaud's phenomenon (RP): a multicentre study in the prospective EULAR Scleroderma Trials and Research database.

antinuclear antibodies raynauds

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 19 April 2013 - 06:56 AM

Systemic sclerosis without antinuclear antibodies (ANA) or Raynaud's phenomenon (RP): a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database.

 

Prospective studies are needed to elucidate the clinical presentation, evolution and outcome of such patients. Pub Med Rheumatology. 2013 Mar;52(3):560-7. (Also see: What is Scleroderma?, Antibodies in Systemic Scleroderma, Raynaud's)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

 

 


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)






Also tagged with one or more of these keywords: antinuclear antibodies, raynauds